Nukkleus Inc. Regains Full Nasdaq Compliance
Nukkleus Inc. (Nasdaq: NUKK), an Aerospace and Defense strategic acquirer, has regained full compliance with Nasdaq Global Market's minimum market capitalization requirement. The company recently secured a $10 million private placement (PIPE) and announced a $250 million line of equity to strengthen its balance sheet and support growth initiatives.
The company has also been added to the Russell Microcap Index, enhancing its visibility in the investment community. These developments are expected to accelerate Nukkleus' strategic acquisition program in the A&D sector and advance its European expansion plans once the registration becomes effective.
Nukkleus Inc. (Nasdaq: NUKK), un acquirente strategico nel settore aerospaziale e della difesa, ha nuovamente soddisfatto i requisiti minimi di capitalizzazione di Nasdaq Global Market. L'azienda ha recentemente assicurato una private placement da 10 milioni di dollari (PIPE) e ha annunciato una linea di capitale proprio da 250 milioni di dollari per rafforzare il bilancio e supportare le iniziative di crescita.
L'azienda è stata anche inserita nel Russell Microcap Index, aumentando la visibilità nel panorama degli investitori. Si prevede che questi sviluppi accelerino il programma di acquisizioni strategiche di Nukkleus nel settore A&D e avanzeranno i piani di espansione europea una volta che la registrazione diventerà effettiva.
Nukkleus Inc. (Nasdaq: NUKK), un adquirente estratégico en aeroespacial y defensa, ha vuelto a cumplir plenamente con el requisito mínimo de capitalización de Nasdaq Global Market. La compañía aseguró recientemente una colocación privada de 10 millones de dólares (PIPE) y anunció una línea de capital de 250 millones de dólares para fortalecer su balance y apoyar iniciativas de crecimiento.
La empresa también ha sido añadida al Russell Microcap Index, aumentando su visibilidad ante la comunidad de inversores. Se espera que estos avances aceleren el programa de adquisiciones estratégicas de Nukkleus en el sector A&D y hagan avanzar sus planes de expansión en Europa una vez que la registro entre en vigor.
Nukkleus Inc. (나스닥: NUKK), 항공우주 및 방위 산업의 전략적 인수업자로서 Nasdaq Global Market의 최소 시가총액 요건을 다시 충족했습니다. 회사는 최근 1000만 달러 규모의 프라이빗 배정(PIPE)을 확보했으며 재무구조를 강화하고 성장 전략을 뒷받침하기 위한 2.5억 달러의 자본 라인을 발표했습니다.
또한 회사가 Russell Microcap Index에 편입되어 투자자 커뮤니티에서의 가시성이 향상되었습니다. 이러한 발전은 A&D 부문의 전략적 인수 프로그램을 가속화하고 등록이 발효되면 유럽 확장 계획을 진전시킬 것으로 기대됩니다.
Nukkleus Inc. (Nasdaq: NUKK), un acquéreur stratégique dans l’aérospatial et la défense, a retrouvé une conformité complète avec l’exigence de capitalisation minimale du Nasdaq Global Market. La société a récemment obtenu une placement privé de 10 millions de dollars (PIPE) et a annoncé une ligne de capitaux propres de 250 millions de dollars pour renforcer son bilan et soutenir ses initiatives de croissance.
La société a également été ajoutée à l’Index Russell Microcap, améliorant sa visibilité auprès de la communauté des investisseurs. Il est prévu que ces développements accélèrent le programme d’acquisitions stratégiques de Nukkleus dans le secteur A&D et avancent ses plans d’expansion européenne une fois l’enregistrement effectif.
Nukkleus Inc. (Nasdaq: NUKK), ein strategischer Akquisitionsführer im Bereich Luft- und Raumfahrt sowie Verteidigung, hat erneut die Mindestmarktkapitalisierungspflicht des Nasdaq Global Market erfüllt. Das Unternehmen hat kürzlich eine Private Placement über 10 Millionen USD (PIPE) gesichert und eine Kapitallinie in Höhe von 250 Millionen USD angekündigt, um die Bilanz zu stärken und Wachstumsinitiativen zu unterstützen.
Das Unternehmen wurde außerdem in den Russell Microcap Index aufgenommen, was die Sichtbarkeit bei der Investoren-Community erhöht. Es wird erwartet, dass diese Entwicklungen das strategische Akquisitionsprogramm von Nukkleus im A&D-Sektor beschleunigen und die europäischen Expansionspläne vorantreiben, sobald die Registrierung wirksam wird.
نَوكْكِلِس إنك (ناسداك: NUKK)، محافظة استراتيجية في مجالي الفضاء والدفاع، قد استوفَت مرة أخرى الحد الأدنى للرسملة السوقية في Nasdaq Global Market. قامت الشركة مؤخرًا بتأمين عملية تخصيص خاصة بقيمة 10 ملايين دولار (PIPE) وأعلنت عن خط حقوق بقيمة 250 مليون دولار لتعزيز ميزانيتها ودعم مبادرات النمو.
كما أُضيفت الشركة إلى Russell Microcap Index، ما عزز من ظهورها في مجتمع المستثمرين. من المتوقع أن تُسرِّع هذه التطورات برنامج الاستحواذات الاستراتيجي في قطاع A&D وتدفع خطط التوسع الأوروبي لديها بمجرد أن تصبح التسجيلات سارية.
Nukkleus Inc.（纳斯达克：NUKK），一家航空航天与国防领域的战略性并购企业，已重新符合纳斯达克全球市场的最低市值要求。公司最近完成了1000万美元的私募配售（PIPE），并宣布了一条2.5亿美元的股权融资线，以强化资产负债表并支持增长计划。
公司还被纳入Russell Microcap Index（罗素微型股指数），提升了在投资者群体中的知名度。这些进展预计将加速Nukkleus在航空航天与防务领域的战略并购计划，并在注册生效后推进其欧洲扩张计划。
- None.
- Registration statement for $250M equity line not yet effective
- Previous compliance issues may have impacted institutional investor confidence
Insights
Nukkleus regains Nasdaq compliance through capital raising, significantly strengthening its position for A&D acquisitions and market credibility.
Nukkleus has successfully addressed a critical regulatory challenge by regaining full compliance with Nasdaq Global Market's minimum market capitalization requirement. This compliance recovery stems from the company's
The resolution of this compliance issue removes a significant overhang that had been limiting institutional investor interest. Nasdaq compliance is particularly important for smaller companies like Nukkleus as non-compliance can trigger forced delisting, severely restricting liquidity and institutional ownership opportunities. The company's simultaneous addition to the Russell Microcap Index further enhances its visibility to index-tracking funds and institutional investors.
For an aerospace and defense-focused acquisition platform like Nukkleus, maintaining Nasdaq listing status is strategically vital. The strengthened balance sheet not only satisfies regulatory requirements but provides capital for the company's stated acquisition strategy in the A&D sector, including European expansion plans. This capital infusion comes at an opportune time when defense sector consolidation is accelerating globally amid heightened geopolitical tensions.
The market capitalization recovery suggests improved investor confidence in Nukkleus' business model as a strategic acquirer in the A&D space. While the company doesn't specify its exact acquisition targets, the substantial equity line indicates ambitions for meaningful acquisitions rather than merely incremental growth. This financial reinforcement positions Nukkleus to potentially capitalize on current market dislocations in the defense technology space where innovative smaller players often lack sufficient capital for growth.
Company’s recent private placement and
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Nukkleus Inc. (Nasdaq: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-growth businesses in the Aerospace and Defense (A&D) industry, today announced that it has regained full compliance with the Nasdaq Global Market’s minimum market capitalization requirement. The Company believes that this milestone, together with its recently announced
The recently disclosed private placement significantly strengthens the Company’s balance sheet and market capitalization, reaffirming its ability to maintain Nasdaq standards. This compliance achievement, combined with Nukkleus' addition to the Russell Microcap Index, is expected to enhance the Company's visibility and credibility with the investment community.
The Company believes the resolution of the Nasdaq deficiency note will help address concerns previously expressed by institutional investors regarding compliance-related risks. Additionally, maintaining Nasdaq compliance and index inclusion is expected to attract enhanced analyst coverage, providing greater market transparency and research support for current and prospective investors.
The private placement is also expected to enable Nukkleus to accelerate its strategic acquisition program in the A&D sector and advance its European expansion plans, once the registration is declared effective. With greater financial flexibility, the Company is positioned to identify and scale high-potential businesses while continuing to deliver consistent, long-term value to shareholders. Nukkleus’ strengthened financial position underscores its operational resilience and strategic focus on building a diversified, innovation-driven A&D platform designed to generate sustainable growth and measurable returns.
"The successful resolution of our compliance matters, coupled with our Russell Microcap Index inclusion and the strong institutional interest we're seeing, marks a pivotal moment for Nukkleus," said Menny Shalom, Chief Executive Officer of Nukkleus Inc. "The planned
About Nukkleus Inc.
Nukkleus Inc. (NASDAQ: NUKK) focuses on acquiring and scaling mission-critical suppliers across the defense, aerospace, and advanced manufacturing sectors. Nukkleus targets Tier 2 and Tier 3 companies that form the industrial backbone of national security infrastructure in the US, Israel and Europe. Through its proprietary capital model, Nukkleus integrates operational capabilities, financial discipline, and long-term vision to modernize and expand strategic suppliers—supporting dual-use innovation and resilient supply chains.
The company’s portfolio approach combines organic growth with disciplined M&A, enabling transformational scale and positioning Nukkleus at the core of 21st-century defense industrial strategy.
Forward Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts, including, but not limited to, statements related to the ability to raise capital as a result of the execution of the credit line agreement and the ability for the Company to utilize the financing to fund acquisitions and business expansion and statements are "forward-looking statements" within the meaning of federal securities laws. In some cases, you can identify forward-looking statements by terminology such as “hopes”, "will," "would," "expect," "intend," "plan," "objective," or comparable terminology referencing future events, conditions or circumstances, or the negative of such terms. Although Nukkleus believes that it has a reasonable basis for the forward-looking statements contained in this press release, they are based on management's current beliefs and expectations about future events and circumstances and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond the Company's control. Risk factors including, but not limited to, the risk that the Company may never draw down on the equity line, the risk that the registration statement for the equity line will not be declared effective, the risk that the acquisitions may not be completed on the terms or in the time frame expected by the company, unexpected costs, charges or expenses resulting from the acquisitions, the ability of the company to implement its business strategy, uncertainty regarding third-party market projections, market volatility, competition, litigation, and those other risks described under "Risk Factors" in Nukkleus' filed annual report on Form 10-K, as updated from time to time in its quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements in this press release. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Nukkleus undertakes no obligation to update any forward-looking statement contained in this press release to reflect events that occur or circumstances that exist after the date of this press release, except as required by law.
For more information, please contact:
Investor Relations (US)
Lena Cati
Tel: +1 212 836-9611
lcati@theequitygroup.com
Val Ferraro
Tel: +1 212 836-9612
vferraro@theequitygroup.com
FAQ
What compliance requirement did Nukkleus (NUKK) regain with Nasdaq?
How much funding did Nukkleus (NUKK) secure in September 2025?
What impact will Nukkleus' Nasdaq compliance have on the company?
What are Nukkleus' (NUKK) plans for the new funding?
What index was Nukkleus (NUKK) added to in 2025?
